Enteric coated oral pharmaceutical to erode kidney stones
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 21, 2009
Grant Date -
Feb 16, 2006
app pub date -
Feb 25, 2005
filing date -
Feb 26, 2004
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A treatment protocol by which a renal stone patient is administered a chelating agent, generally once a day and preferably by mouth, during a treatment phase and is later administered the same chelating agent once a week, during a “maintenance” phase. The chelating agent is most preferably ethylene diamine tetraacetic acid (EDTA) and may be provided in a dosage form having an enteric coating and at least one external cathode and at least one external anode to create a galvanic current upon contact of the dosage form with the patient's intestinal contents.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully